We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Clopidogrel 75mg film-coated tablets (Zentiva, UK)
Section 19A approved medicine
Clopidogrel 75mg film-coated tablets (Zentiva, UK)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 517
Phone
1800 181 060
Approved until
Status
Current
Medicines in short supply/unavailable
PLIDOGREL clopidogrel (as besilate) 75 mg tablet blister pack - ARTG 218326
CLOPIDOGREL SANDOZ PHARMA clopidogrel (as hydrogen sulfate) 75 mg, film coated tablets, blister pack - ARTG 187042
CLOPIDOGREL SANDOZ PHARMA clopidogrel (as hydrogen sulfate) 75 mg, film coated tablets, blister pack - ARTG 187042
Indication(s)
Prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease.
PLIDOGREL is indicated in combination with aspirin for patients with:
- Unstable angina or non-ST-elevation myocardial infarction in order to prevent early and long-term atherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischaemia). PLIDOGREL is indicated for the treatment of acute coronary syndrome whether or not patients undergo cardiac revascularisation (surgical or PCI, with or without stent).
- ST-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. In this population, PLIDOGREL has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke in medically treated patients eligible for thrombolytic therapy.
Images
